165 related articles for article (PubMed ID: 19258400)
1. Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients.
Fukami M; Nishimura G; Homma K; Nagai T; Hanaki K; Uematsu A; Ishii T; Numakura C; Sawada H; Nakacho M; Kowase T; Motomura K; Haruna H; Nakamura M; Ohishi A; Adachi M; Tajima T; Hasegawa Y; Hasegawa T; Horikawa R; Fujieda K; Ogata T
J Clin Endocrinol Metab; 2009 May; 94(5):1723-31. PubMed ID: 19258400
[TBL] [Abstract][Full Text] [Related]
2. Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency.
Fukami M; Nagai T; Mochizuki H; Muroya K; Yamada G; Takitani K; Ogata T
Mol Genet Metab; 2010 Jul; 100(3):269-73. PubMed ID: 20409737
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients.
Fukami M; Horikawa R; Nagai T; Tanaka T; Naiki Y; Sato N; Okuyama T; Nakai H; Soneda S; Tachibana K; Matsuo N; Sato S; Homma K; Nishimura G; Hasegawa T; Ogata T
J Clin Endocrinol Metab; 2005 Jan; 90(1):414-26. PubMed ID: 15483095
[TBL] [Abstract][Full Text] [Related]
4. Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites.
Soneda S; Yazawa T; Fukami M; Adachi M; Mizota M; Fujieda K; Miyamoto K; Ogata T
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1881-7. PubMed ID: 21900384
[TBL] [Abstract][Full Text] [Related]
5. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals.
Camats N; Pandey AV; Fernández-Cancio M; Andaluz P; Janner M; Torán N; Moreno F; Bereket A; Akcay T; García-García E; Muñoz MT; Gracia R; Nistal M; Castaño L; Mullis PE; Carrascosa A; Audí L; Flück CE
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1294-306. PubMed ID: 22549935
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies.
Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE
Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274
[TBL] [Abstract][Full Text] [Related]
7. A case of Antley-Bixler syndrome caused by compound heterozygous mutations of the cytochrome P450 oxidoreductase gene.
Ko JM; Cheon CK; Kim GH; Yoo HW
Eur J Pediatr; 2009 Jul; 168(7):877-80. PubMed ID: 18853185
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
Bai Y; Li J; Wang X
J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
Fukami M; Ogata T
Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
[TBL] [Abstract][Full Text] [Related]
10. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
[TBL] [Abstract][Full Text] [Related]
12. Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency.
Koika V; Armeni AK; Georgopoulos NA
Hormones (Athens); 2016 Apr; 15(2):277-282. PubMed ID: 27376429
[TBL] [Abstract][Full Text] [Related]
13. Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.
Lee Y; Choi JH; Oh A; Kim GH; Park SH; Moon JE; Ko CW; Cheon CK; Yoo HW
Ann Pediatr Endocrinol Metab; 2020 Jun; 25(2):97-103. PubMed ID: 32615689
[TBL] [Abstract][Full Text] [Related]
14. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
15. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.
Fan L; Ren X; Song Y; Su C; Fu J; Gong C
Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681
[TBL] [Abstract][Full Text] [Related]
16. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
Evans WE; Relling MV
Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
[TBL] [Abstract][Full Text] [Related]
17. Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency.
But WM; Lo IF; Shek CC; Tse WY; Lam ST
Hong Kong Med J; 2010 Feb; 16(1):59-62. PubMed ID: 20124576
[TBL] [Abstract][Full Text] [Related]
18. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.
Johnson MR; Wang K; Diasio RB
Clin Cancer Res; 2002 Mar; 8(3):768-74. PubMed ID: 11895907
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency.
Zhang T; Li Z; Ren X; Huang B; Zhu G; Yang W; Jin L
J Assist Reprod Genet; 2020 Oct; 37(10):2503-2511. PubMed ID: 32725309
[TBL] [Abstract][Full Text] [Related]
20. Concomitant mutations in the P450 oxidoreductase and androgen receptor genes presenting with 46,XY disordered sex development and androgenization at adrenarche.
Idkowiak J; Malunowicz EM; Dhir V; Reisch N; Szarras-Czapnik M; Holmes DM; Shackleton CH; Davies JD; Hughes IA; Krone N; Arlt W
J Clin Endocrinol Metab; 2010 Jul; 95(7):3418-27. PubMed ID: 20410220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
